Basic Searches
Searches without any special characters (listed below) will return items that contain the exact value(s) entered in the search field. This means that searching for "ASPIRIN CALCIUM" won't return any items that have "ASPIRIN GLYCINE CALCIUM" because the search term doesn't match exactly.
Boolean Operators
OR - searches with terms separated by " OR " will return items that contain any of the terms in the search.
Example: "ASPIRIN" OR "CALCIUM" will return items that have strings like "ASPIRIN GLYCINE" and "GLYCINE CALCIUM" because they contain at least one of the terms in the search.

AND - searches with terms separated by " AND " will return items that contain all the terms in the search.
Example: "ASPIRIN" AND "CALCIUM" won't return items that have strings "ASPIRIN GLYCINE" and "GLYCINE CALCIUM" because neither contain both terms, but it will return "ASPIRIN GLYCINE CALCIUM" because it contains both search terms.
version 2.5
Substance Class Protein
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type UNKNOWN
Record UNII
2BT4C47RUI
Record Status Validated (UNII)
Record Version
Show Definitional References Hide Definitional References
Download
Name Type Language Details References
NECITUMUMAB
Domain Jurisdiction Naming Organization
drug  
INN   USAN  
DASH   INN   MI   USAN   WHO-DD  
Official Name
English  
NECITUMUMAB [USAN]
Common Name
English  
NECITUMUMAB [PURPLE BOOK, CDER]
Common Name
English  
11F8
Code
English  
IMC-11F8
Code
English  
NECITUMUMAB [MI]
Common Name
English  
NECITUMUMAB [WHO-DD]
Common Name
English  
NECITUMUMAB [INN]
Common Name
English  
PORTRAZZA
Brand Name
English  
NECITUMUMAB [JAN]
Common Name
English  
Classification Tree Code System Code References
EMA ASSESSMENT REPORTS PORTRAZZA (AUTHORISED: CARCINOMA, NON-SMALL-CELL LUNG)
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
WHO-ATC L01XC22
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
NCI_THESAURUS C133878
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
NCI_THESAURUS C129822
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
NDF-RT N0000175664
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
FDA ORPHAN DRUG 418213
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
Code System Code Type Description References
WIKIPEDIA
NECITUMUMAB
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
PRIMARY
EVMPD
SUB33032
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
PRIMARY
LactMed
906805-06-9
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
PRIMARY
NCI_THESAURUS
C88281
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
PRIMARY
MERCK INDEX
M7790
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
PRIMARY Merck Index
RXCUI
1723738
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
PRIMARY RxNorm
CAS
906805-06-9
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
PRIMARY
ChEMBL
CHEMBL1743047
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
PRIMARY
INN
9083
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
PRIMARY
From To
1_22 1_97
1_148 1_204
1_265 1_325
1_371 1_429
2_22 2_97
2_148 2_204
2_265 2_325
2_371 2_429
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
1_224 3_214
2_224 4_214
1_230 2_230
1_233 2_233
Glycosylation Link Type Site
N 1_301
N 2_301
Related Record Type Details References
TARGET -> INHIBITOR
none
Mediator Substance Details
none
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
Related Record Type Details References
ACTIVE MOIETY
none
none
Mediator Substance Details
none
Created by admin on Thu Mar 26 03:18:26 EDT 2020 , Edited by admin on Thu Mar 26 03:18:26 EDT 2020
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC Elimination
PHARMACOKINETIC
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL 0
Vdss PHARMACOKINETIC
Note References
[Validation]WARNING:Code 'N0000175664'[NDF-RT] collides (possible duplicate) with existing code & codeSystem for substance:
[PQX0D8J21J]CETUXIMAB
Created Thu Mar 26 03:18:26 EDT 2020
Created By admin
Last Edited Thu Mar 26 03:18:26 EDT 2020
Last Edited By admin
Index Source Text / Citation Source Type Tags Date Accessed File
1 SRS import [2BT4C47RUI] SRS NOMEN Fri Apr 28 14:57:25 EDT 2017
2 http://www.forbes.com/sites/davidkroll/2013/08/14/possible-efficacy-of-necitumumab-imc-11f8-in-squam SRS NOMEN
3 USAN COUN 2009 USANCOUN NOMEN PUBLIC_DOMAIN_RELEASE
4 CHEMBL SRS NOMEN
5 JAN SRS NOMEN PUBLIC_DOMAIN_RELEASE
6 NECITUMUMAB [WHO-DD] SRS_LOCATOR
7 http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89bcf553-669a-40b0-a9d7-67a5c1d2f591 SRS NOMEN
8 https://en.wikipedia.org/wiki/Necitumumab WIKI
9 USP DICTIONARY 2011 SRS NOMEN
10 INN 2010 SRS NOMEN
11 NECITUMUMAB [DASH] SRS_LOCATOR
12 INN INN NOMEN
13 Drug Information Handbook, 2016-2017 - 25th edition; Lexicomp Drug Reference Handbook; ISBN13: 9781591953531 BOOK PUBLIC_DOMAIN_RELEASE
14 STN STN (SCIFINDER)
15 SRS CODE IMPORT SRS NOMEN Fri Apr 28 14:57:25 EDT 2017
16 GSRS System-generated Validation messages VALIDATION_MESSAGE Thu Mar 26 03:18:24 EDT 2020
17 GSRS System-generated Validation messages VALIDATION_MESSAGE Thu Mar 26 03:18:24 EDT 2020
18 inn SRS NOMEN PUBLIC_DOMAIN_RELEASE AUTO_SELECTED
19 PURPLE BOOK CDER SRS
20 NECITUMUMAB [INN] SRS_LOCATOR
21 NECITUMUMAB [MI] SRS_LOCATOR
22 NECITUMUMAB [USAN] SRS_LOCATOR
23 SYSTEM
24 WEBSITE WEBSITE NOMEN PUBLIC_DOMAIN_RELEASE
25 WHO-DD SRS NOMEN
26 MERCK SRS NOMEN